Novo to Debut Real-World Wegovy vs Resmetirom MASH Data at AASLD 2025
Novo Nordisk will unveil real-world PLATINUM-Truveta data comparing semaglutide 2.4 mg with resmetirom in MASH at AASLD 2025, with results still undisclosed.
Novo Nordisk will unveil real-world PLATINUM-Truveta data comparing semaglutide 2.4 mg with resmetirom in MASH at AASLD 2025, with results still undisclosed.